Why it matters: Novo Nordisks first-to-market approval is an advantage not only for the company but also for potential patients who are needle-averse or prefer the convenience of a pill
Your body releases it in pulses, and the largest surges happen during deep sleep
The Lancet Psychiatry, 13, 327-335.
Cell 140(6):918934 Gordon R, Albornoz EA, Christie DC, Langley MR, Adamczak SE, Lane SD, Schiapacassi AC, Vijayakumar SL, ONeil JD, Akiba Y, Li S, Yerbury JJ, Blair IP, Park H, Cherny RA, Bush AI, Halliday GM, Gupta AS, Reiman EM, Shakespear SK (2018) Inflammasome activation in Parkinsons disease: A target for neuroprotection
The answer to that is emphatically yes
Carafa V, Altucci L